John VandermostenSenior Biotech Analyst at Zacks
John Vandermosten is a senior biotechnology research analyst for Zacks SCR where he covers a portfolio of small cap equities. His background includes 18 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. Formerly, John was a research analyst for Singular Research covering the health care space and a consultant with Coker Group, a national healthcare services firm providing financial services to health care organizations. At Coker Group he consulted with clients in a variety of strategic and financial areas, including asset valuations, due diligence and transactions. Prior to his role as sell-side analyst and consultant, John was a portfolio manager at Westwood Holdings Group and covered health care and other spaces as research analyst. John was also an analyst at the Teacher Retirement System of Texas. John has an MBA from Texas A&M University, an MA from Tulane University and a BA from San Diego State University. He has also earned the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Dallas.